Sandeep Datta, MD
Interventional Pain Medicine · Macon, GANPI 1477546166
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Boston Scientific at 42.0% of the total. Among interventional pain medicine clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 494 payments — averaging $56.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$12K
- Medtronic$7K
- Surgentec$4K
- Curonix LLC$1K
- Nevro Corp.$1K
- SPR Therapeutics, Inc$407
- plus $3K from 24 others
What the payments were for
- Travel & lodging$12,75046%
- Food & beverage$14,89354%
- Education$1110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 207 | $11,653 |
| Medtronic(2 entities) | 106 | $7,097 |
| Surgentec | 1 | $3,686 |
| Curonix LLC | 16 | $1,223 |
| Nevro Corp. | 26 | $1,006 |
| SPR Therapeutics, Inc | 5 | $407 |
| Collegium Pharmaceutical, Inc. | 23 | $390 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 23 | $384 |
| Scilex Pharmaceuticals Inc. | 21 | $359 |
| Nalu Medical, Inc. | 12 | $330 |
| Biodelivery Sciences International, Inc. | 7 | $308 |
| Vertos Medical, Inc. | 3 | $215 |
| Daiichi Sankyo Inc. | 10 | $111 |
| Pfizer | 7 | $105 |
| Abbott | 5 | $90 |
| Globus Medical | 3 | $54 |
| Forte Bio-pharma LLC | 3 | $49 |
| Relievant Medsystems, Inc. | 2 | $41 |
| Bioventus LLC | 1 | $36 |
| IBSA Pharma Inc. | 2 | $33 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Redhill Biopharma Inc. | 1 | $23 |
| Flowonix Medical Incorporated | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Vertex | 1 | $16 |
| Amgen | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Shionogi Inc | 1 | $13 |
| Pernix Therapeutics Holdings, Inc. | 1 | $13 |
| Assertio Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ION$3,686
- GENERAL - THERAPIES$2,143
- SYNCHROMEDII$1,906
- INTELLIS ADAPTIVESTIM$1,896
- KYPHON EXPRESS II KYPHOPAK TRAY$825
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$821
- GENERAL PAIN MANAGEMENT$731
- WaveWriter Alpha Prime 16$442
- Superion Indirect Decompression System$268
- Senza$238
- BELBUCA$237
- SPRINT PNS System$232
- G4 RF Generator$146
- Senza Spinal Cord Stimulation System$135
- INCEPTIV$134
- SPECTRA WAVEWRITER$113
- INTELLIS$104
- mild Device Kit$102
How this compares
$27,753 in reported general payments places this provider in the 90th percentile of 129 interventional pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 3,030 | $74,207 |
| BelbucaBuprenorphine Hcl | 70 | $50,270 |
| Buprenorphine | 115 | $33,735 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 767 | $20,521 |
| NucyntaTapentadol Hcl | 12 | $13,836 |
| ZtlidoLidocaine | 14 | $7,507 |
| OxycontinOxycodone Hcl | 12 | $7,052 |
| Oxycodone Hcl | 326 | $4,959 |
| Morphine Sulfate ErMorphine Sulfate | 139 | $3,756 |
| Lidocaine | 31 | $3,022 |
| Gabapentin | 180 | $1,810 |
| Diclofenac Sodium | 22 | $1,508 |
| Tramadol Hcl | 167 | $1,326 |
| Fentanyl | 11 | $1,296 |
| Pregabalin | 95 | $1,134 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta | $390 | $64,10682 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $359 | $7,50714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 129 interventional pain medicine providers in Georgia.
Other interventional pain medicine in Macon
- Stephen TaforMacon$16K
- Margaret BoltjaMacon$7K
- Jeremy PrineMacon$7K
- Emmanuel GageBrunswick$602K
- Jordan TateJasper$540K
- Christopher BovinetBrunswick$338K
- David RosenfeldCovington$249K
- Nathan NeufeldNewnan$171K
- Ryan BudwanyLawrenceville$123K
- Alexandra MoreiraAtlanta$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.